PH vs TRAW · P/E 28, rev $19.85B vs rev $226.0K
Parker-Hannifin Corporation (PH) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported TRAW revenue for 2024-12-31 was $226.0K. Net income was -$166.5M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. TRAW currently screens at market cap $12.1M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the PH and TRAW stock pages for the full models.
Not investment advice.